Reaction

Endophthalmitis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 5,919 reports · 104 co-occurring drugs

As of the last recalculation, Endophthalmitis appears in 5,919 FAERS reports alongside 104 co-occurring drug terms. The strongest observed disproportionality signal is AFLIBERCEPT (PRR 208.1).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Aflibercept	1,409	208.1	218.0
Faricimab	259	117.5	121.3
Ranibizumab	734	110.9	114.0
Prednisolone Acetate	181	63.4	64.5
Moxifloxacin Hydrochloride	295	53.8	54.6
Bevacizumab	1,199	42.4	42.8
Amphotericin B	125	35.8	36.2
Moxifloxacin	134	34.2	34.5
Dexamethasone Sodium Phosphate	79	27.7	27.9
Tobramycin Solution	87	25.8	26.0
Voriconazole Injection	152	25.2	25.4
Tobramycin Sulfate	87	25.1	25.2
Triamcinolone Acetonide	175	20.5	20.6
Voriconazole	158	18.8	18.9
Atropine Sulfate	54	17.7	17.8
Cefuroxime	50	15.5	15.6
Atropine	35	14.9	15.0
Vancomycin Hydrochloride	258	14.3	14.4
Vancomycin	224	14.1	14.2
Tobramycin	94	13.9	14.0
Posaconazole Delayed-Release	34	10.9	11.0
Triamcinolone Acetonide Ointment Usp, 0.05%	68	10.3	10.3
Linezolid	84	10.1	10.1
Gentamicin Sulfate	42	9.4	9.4
Piperacillin Sodium,Tazobactam Sodium	64	8.6	8.6
Itraconazole	25	7.6	7.6
Piperacillin And Tazobactam	27	7.5	7.5
Posaconazole	34	7.4	7.4
Dexamethasone	569	7.4	7.4
Brinzolamide	18	7.3	7.3
Lidocaine Hydrochloride And Epinephrine Bitartrate	109	7.3	7.3
Lidocaine Hydrochloride	120	7.1	7.1
Terbinafine Hydrochloride	17	6.7	6.8
Dorzolamide Hydrochloride And Timolol Maleate	15	6.7	6.7
Tacrolimus Ointment 0.1%	222	6.5	6.5
Tacrolimus Extended-Release Capsules	222	6.5	6.5
Timolol Maleate	17	6.0	6.1
Gentamicin	22	5.9	5.9
Nevirapine	15	5.9	5.9
Timolol	20	5.8	5.8
Brimonidine Tartrate	28	5.5	5.6
Adrenalinum	64	5.5	5.5
Tacrolimus	233	5.4	5.4
Lidicaine	73	5.3	5.3
Burn Relief	73	5.3	5.3
Lidocaine Hydrochloride And Epinephrine	73	5.3	5.3
Lidocaine, Menthol	73	5.2	5.2
Ganciclovir	15	5.2	5.2
Mycophenolate Mofetil	193	5.1	5.1
Mycophenolate Mofetil Hydrochloride	193	5.1	5.1
Lidocaine 4%	77	5.0	5.0
Ganciclovir Sodium	15	5.0	5.0
Ciprofolxacin	98	4.9	4.9
Ciprofloxacin Tablets	98	4.9	4.9
Piperacillin Sodium And Tazobactam Sodium	27	4.9	4.9
Lidocaine	77	4.7	4.7
Ampicillin	11	4.7	4.7
Ampicillin Sodium	11	4.7	4.7
Pegaspargase	16	4.6	4.6
Ciprofloxacin Hydrochloride	125	4.6	4.6
Valganciclovir Hydrochloride Powder,	15	4.3	4.3
Remdesivir	16	4.2	4.2
Levofloxacin	71	4.2	4.2
Levofloxacin In 5% Dextrose	71	4.2	4.2
Ciprofloxacin	103	4.0	4.0
Prednisolone	199	4.0	4.0
Prednisolone Oral	199	4.0	4.0
Prednisolone Oral Solution	199	4.0	4.0
Epinephrine	66	3.6	3.6
Bimatoprost	27	3.3	3.3
Mycophenilic Acid	19	3.2	3.2
Indomethacin	12	3.2	3.2
Valganciclovir	17	3.2	3.2
Valganciclovir Hydrochloride	17	3.2	3.2
Drs. Clotrimazole	10	3.0	3.0
Family Wellness Clotrimazole	10	3.0	3.0
Clotrimazole Topical	10	3.0	3.0
Telmisartan	15	3.0	3.0
Clotrimazole	10	2.9	2.9
Travoprost	7	2.8	2.8
Rifampicin	8	2.8	2.8
Diclofenac Sodium 1%	28	2.8	2.8
Diclofenac Sodium Topical	28	2.8	2.8
Diclofenac Sodium Topical Gel, 1%	28	2.8	2.8
Dexamethasone 1.5 Mg	220	2.7	2.7
Basiliximab	9	2.7	2.7
Ceftriaxone	25	2.7	2.7
Ceftriaxone Sodium	26	2.4	2.4
Terazosin Hydrochloride	6	2.4	2.4
Mycophenolic Acid	21	2.3	2.3
Amikacin	11	2.3	2.3
Latanoprost	32	2.2	2.2
Cefepime Hydrochloride	10	2.2	2.2
Anti-Thymocyte Globulin (Rabbit)	5	2.2	2.2
Micafungin Sodium	5	2.1	2.1
Cefepime	8	2.0	2.0
Lamivudine Oral	14	1.9	1.9
Carboxymethylcellulose Sodium	5	1.9	1.9
Cytarabine	31	1.8	1.8
Salicylic Acid	26	1.7	1.7
Erlotinib	4	1.5	1.5
Panitumumab	6	1.3	1.3
Alteplase	5	1.2	1.2
Lifitegrast	3	0.6	0.6

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.